Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
Active, not recruiting · NCT04906395 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-09-29 | NCT04906395 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tolmar Inc. | 4 |
59 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.